Rheumatoid Arthritis
0108
(NQF #0054)
Rheumatoid Arthritis (RA): Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy
National Quality Strategy Domain: Effective Clinical Care
Was patient prescribed, dispensed, or administered at least one disease modifying anti-rheumatic drug (DMARD) during the measurement period?
May include prescription given to the patient for DMARD therapy at one or more visits in the 12-month period OR patient already taking DMARD therapy as documented in current medication list.

Disease modifying anti-rheumatic drug therapy prescribed, dispensed, or administered.
(4187F)(Performance Met)
4187F

Documentation of medical reason(s) for not prescribing, dispensing, or administering disease modifying anti-rheumatic drug therapy (ie, patients with a diagnosis of HIV or pregnancy)
(4187F:1P)(Medical Performance Exclusion)
4187F:1P

Disease modifying anti-rheumatic drug therapy was not prescribed, dispensed, or administered, reason not otherwise specified.
(4187F:8P)(Performance Not Met)
4187F:8P
X
y
y
0128
(NQF 0421)
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
National Quality Strategy Domain: Community/Population Health\nNOTE: Normal parameters:\nAge 65 years and older BMI  23 and < 30 kg/m2\n
Age 18 - 64 years BMI >= 18.5 and < 25 kg/m2
Was height and weight measured and recorded within 6 months of the encounter?
BMI is documented within normal parameters and no follow-up plan is required.
(G8420) (Performance Met)
G8420
BMI is documented above normal parameters and a follow-up plan is documented.
(G8417) (Performance Met)
G8417
BMI is documented below normal parameters and a follow-up plan is documented.
(G8418) (Performance Met)
G8418
BMI not documented and no reason is given.
(G8421) (Performance Not Met)
G8421
BMI documented outside normal parameters, no follow-up plan documented, no reason given
(G8419) (Performance Not Met)
G8419
X
y
y
0131
(NQF 0420)
Pain Assessment and Follow-Up
National Quality Strategy Domain: Communication and Care Coordination
Was pain assessed using a standardized tool and documented if pain is present?
Documentation of pain assessment for patients aged 18 and older.
Pain assessment documented as positive using a standardized tool AND a follow-up plan is documented.
(G8730)(Performance Met)
G8730
Pain assessment using a standardized tool is documented as negative, no follow-up plan required.
(G8731)(Performance Met)
G8731
Pain assessment NOT documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool.
(G8442) (Other Performance Exclusion)
G8442
Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible.
(G8939) (Other Performance Exclusion)
G8939
No documentation of pain assessment, reason not given.
(G8732) (Performance Not Met)
G8732
Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given.
(G8509) (Performance Not Met)
G8509
X
y
y
0176
(NQF#0000)
Rheumatoid Arthritis (RA): Tuberculosis Screening
National Quality Strategy Domain: Effective Clinical Care
Is patient for whom a TB screening was performed and results interpreted within 6 months prior to receiving a first course of therapy using a biologic disease-modifying anti-rheumatic drug?
Includes Adalimunab, Etanercept, Infliximab, Abatacept, Anakinra (Rituximab is excluded).

TB screening performed and results interpreted within six months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for RA.\\nAND Patient receiving first-time biologic disease modifying anti-rheumatic drug therapy for rheumatoid arthritis.
(3455F, 4195F)(Performance Met)
3455F 4195F

Documentation of medical reason for not screening for TB or interpreting results (ie, patient positive for TB and documentation of past treatment; patient who has recently completed a course of anti-TB therapy).\\nAND Patient receiving first-time biologic disease modifying anti-rheumatic drug therapy for rheumatoid arthritis.
(3455F:1P, 4195F)(Medical Performance Exclusion)
3455F:1P 4195F

Patient not receiving first-time biologic disease modifying anti-rheumatic drug therapy for rheumatoid arthritis.
(4196F)(Other Performance Exclusion)
4196F

TB screening not performed or results not interpreted, reason not otherwise specified.\\nAND Patient receiving first-time biologic disease modifying anti-rheumatic drug therapy for rheumatoid arthritis.
(3455F:8P, 4195F) (Performance Not Met)
3455F:8P 4195F
X
y
y

0177
(NQF#0000)
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity
National Quality Strategy Domain: Effective Clinical Care

Did patient with a rheumatoid arthritis diagnosis undergo an assessment and classification of disease activity within 12 months?
Patients with disease activity assessed by a standardized descriptive or numeric scale or composite index and classified into one of the following categories: low, moderate or high, at least once within 12 months.
Rheumatoid arthritis (RA) disease activity, low.
(3470F) (Performance Met)
3470F

Rheumatoid arthritis (RA) disease activity, moderate.
(3471F)(Performance Met)
3471F

Rheumatoid arthritis (RA) disease activity, high. 
(3472F)(Performance Met)
3472F

Disease activity not assessed and classified, reason not otherwise specified.
(3470F:8P)(Performance Not Met) 
3470F
X
y
y


0178
(NQF#0000)

Rheumatoid Arthritis (RA): Functional Status Assessment
National Quality Strategy Domain: Effective Clinical Care

Did patient with diagnosis of rheumatoid arthritis (RA) undergo a functional status assessment at least once within 12 months?
.

Functional status assessed.
(1170F)(Performance Met)
1170F

Functional status not assessed, reason not otherwise specified.
(1170F:8P)(Performance Not Met)
1170F:8P

X
y
y

0179
(NQF#0000)

Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis
National Quality Strategy Domain: Effective Clinical Care

Did patient with diagnosis of rheumatoid arthritis (RA) undergo an assessment and classification of disease prognosis at least once within 12 months?
Patients with at least one documented assessment and classification (good/poor) of disease prognosis utilizing clinical markers of poor prognosis within 12 months.

Disease prognosis for rheumatoid arthritis assessed, poor prognosis documented.
(3475F)(Performance Met)
3475F

Disease prognosis for rheumatoid arthritis assessed, good prognosis documented.
(3476F)(Performance Met)
3476F

Disease prognosis for rheumatoid arthritis not assessed and classified, reason not otherwise specified.
(3475F:8P)(Performance Not Met)
3475F:8P 

X
y
y

0180
(NQF#0000)

Rheumatoid Arthritis (RA): Glucocorticoid Management
National Quality Strategy Domain: Effective Clinical Care

Did patient with diagnosis of rheumatoid arthritis (RA) undergo assessment for glucocorticoid use and, for those on prolonged doses of prednisone = 10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid management plan within 12 months.
Patients aged 18 and older.

Patient not receiving glucocorticoid therapy.
(4192F)(Performance Met) 
4192F

Patient receiving < 10 mg daily prednisone (or equivalent), or RA activity is worsening, or glucocorticoid use is for less than 6 months.
(4193F)(Performance Met) 
4193F

Patient receiving = 10 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity.\\nAND Glucocorticoid Management Plan documented.
(4194F, 0540F)(Performance Met) 
4194F 0540F

Documentation of medical reason(s) for not documenting glucocorticoid management plan (ie, glucocorticoid prescription is for a medical condition other than RA).\\nAND Patient receiving = 10 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity.
(0540F:1P, 4194F)(Medical Performance Exclusion)
0540F:1P 4194F

Glucocorticoid dose was not documented, reason not otherwise specified.
(4194F:8P)(Performance Not Met)  
4194F:8P

Glucocorticoid management plan not documented, reason not otherwise specified.\\nAND Patient receiving = 10 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity.
(0540F:8P, 4194F)(Performance Not Met) 
0540F:8P 4194F

X
y
y

0337
(NQF#0000)

Tuberculosis Prevention for Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier
National Quality Strategy Domain: Effecitve Clincal Care

Does patient record inclue documented negative annual TB screening or documentation of the management of a positive TB screening test with no evidence of active tuberculosis through use of radiographic imaging (i.e., chest x-ray, CT)?
.

Documentation of negative or managed positive TB screen with further evidence that TB is not active.
(G9359)(Performance Met) 
G9359

No documentation of negative or managed positive TB screen.
(G9360)(Performance Not Met)
G9360

X
y
n
 
